Compounds > valerates
Page last updated: 2024-09-02

valerates and Coronary Disease

valerates has been researched along with Coronary Disease in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-199013 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grundy, SM1
Elo, MO; Frick, MH; Haapa, K; Heinonen, OP; Heinsalmi, P; Helo, P; Huttunen, JK; Kaitaniemi, P; Koskinen, P; Manninen, V1
Dodge, HT; Kostis, JB; Kuo, PT; Moreyra, AB; Wilson, AC1
Bell, H; Dittmeier, G; Martinez, L1
Elo, O; Frick, MH; Haapa, K; Heinonen, OP; Heinsalmi, P; Helo, P; Huttunen, JK; Kaitaniemi, P; Koskinen, P; Manninen, V1
Rifkind, BM1
Elo, O; Frick, MH; Haapa, K; Heinonen, OP; Heinsalmi, P; Helo, P; Huttunen, JK; Kaitaniemi, P; Koskinen, P; Mänttäri, M1
Heinonen, OP; Javela, K; Mäenpää, H; Mälkönen, M; Manninen, V; Pikkarainen, J1
Heinonen, OP; Mäenpää, H; Manninen, V1
Grundy, SM; Vega, GL1
Manninen, V1
Babenko, GA; Vandzhura, IP1

Trials

9 trial(s) available for valerates and Coronary Disease

ArticleYear
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
    JAMA, 1988, Aug-05, Volume: 260, Issue:5

    Topics: Adult; Coronary Disease; Double-Blind Method; Finland; Gemfibrozil; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Myocardial Infarction; Pentanoic Acids; Random Allocation; Risk Factors; Valerates

1988
Gemfibrozil therapy in patients with coronary heart disease.
    Missouri medicine, 1988, Volume: 85, Issue:1

    Topics: Adult; Cholesterol, HDL; Clinical Trials as Topic; Coronary Disease; Female; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Valerates

1988
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
    The New England journal of medicine, 1987, Nov-12, Volume: 317, Issue:20

    Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Finland; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Random Allocation; Risk Factors; Triglycerides; Valerates

1987
Gemfibrozil, lipids, and coronary risk.
    The New England journal of medicine, 1987, Nov-12, Volume: 317, Issue:20

    Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Random Allocation; Valerates

1987
The Helsinki Heart Study: basic design and randomization procedure.
    European heart journal, 1987, Volume: 8 Suppl I

    Topics: Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Finland; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Random Allocation; Valerates

1987
Minimal doses of digoxin: a new marker for compliance to medication.
    European heart journal, 1987, Volume: 8 Suppl I

    Topics: Clinical Trials as Topic; Coronary Disease; Creatinine; Digoxin; Double-Blind Method; Finland; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Patient Compliance; Pentanoic Acids; Random Allocation; Valerates

1987
Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial.
    European heart journal, 1987, Volume: 8 Suppl I

    Topics: Capsules; Clinical Trials as Topic; Coronary Disease; Creatinine; Digoxin; Double-Blind Method; Finland; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Patient Compliance; Pentanoic Acids; Random Allocation; Valerates

1987
Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
    JAMA, 1985, Apr-26, Volume: 253, Issue:16

    Topics: Adult; Aged; Apolipoproteins B; Cholesterol, LDL; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates

1985
The Gemfibrozil Study.
    Acta medica Scandinavica. Supplementum, 1985, Volume: 701

    Topics: Adult; Clinical Trials as Topic; Coronary Disease; Female; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pentanoic Acids; Valerates

1985

Other Studies

4 other study(ies) available for valerates and Coronary Disease

ArticleYear
Gemfibrozil and coronary heart disease.
    The New England journal of medicine, 1988, May-12, Volume: 318, Issue:19

    Topics: Accidents; Adult; Coronary Disease; Gemfibrozil; Humans; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Valerates; Violence

1988
Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia.
    Postgraduate medicine, 1988, Volume: 84, Issue:1

    Topics: Adult; Bile Acids and Salts; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates

1988
Treatment of type III hyperlipoproteinemia with gemfibrozil to retard progression of coronary artery disease.
    American heart journal, 1988, Volume: 116, Issue:1 Pt 1

    Topics: Adult; Combined Modality Therapy; Coronary Disease; Drug Evaluation; Exercise Test; Female; Gemfibrozil; Hand Dermatoses; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Valerates; Xanthomatosis

1988
[Use of zinc valerate in the complex treatment of ischemic disease].
    Vrachebnoe delo, 1971, Volume: 8

    Topics: Coronary Disease; Humans; Valerates; Zinc

1971